The Need for Speed: Maximising Adeno-Associated Virus (AAV) Vector Productivity with High Throughput (HTP) Platforms
At Pharmaron, we have successfully developed a platform process for the production of AAV gene therapies with a highly adaptive toolbox to manage varying products and serotypes.
To learn more about Pharmaron’s high throughput processing capabilities, please complete the form below to download the poster: The Need for Speed: Maximising Adeno-Associated Virus (AAV) vector productivity with high throughput (HTP) platforms.